March 24, 2026

Ablation vs Surgery Outcomes for Small RCC

Minimally invasive therapy offers perioperative advantages in registry analysis.

Conexiant

March 23, 2026

AI Model Differentiates BCC vs cSCC Subtypes

External validation identifies calibration shift in COBRA cohort.

Conexiant

March 23, 2026

Renal Imaging Strategies Put to the Test

Noncontrast MRI technique evaluates renal tumor characterization in rapid acquisition.

Conexiant

March 19, 2026

Sleeve vs Gastric Bypass: Nutrient Intake at 1 Year

Investigators analyze 4-day food records and supplement reports from 285 patients at seven Swedish metabolic and bariatric centers in a substudy of the randomized BEST trial.

Conexiant

March 18, 2026

Medical Oddities: Friends, Family… and Faster Aging?

From gut gas trackers to bat vaccines, relationships and aging, GLP-1 hair shifts, and bug-based delivery—medicine keeps getting creative.

Conexiant

March 16, 2026

Beyond Morphology and IHC

Can molecular profiling and AI help uncover tumor origin and actionable biomarkers?

The Pathologist

March 13, 2026

p53 Reactivator Rezatapopt in TP53 Y220C–Mutated Solid Tumors

In a phase I trial (PYNNACLE) reported in The New England Journal of Medicine, Dumbrava et al described the toxicity and preliminary activity of rezatapopt in TP53 Y220C–mutated solid tumors. The agen...

The ASCO Post

March 06, 2026

Are AI Models Cheating in Biomarker Predictions?

Study finds image-based predictions often reflect confounding factors rather than true molecular signals

The Pathologist

March 05, 2026

Why One Number Isn’t Enough for Patients

Adding a comparison number may help patients interpret risk and make better decisions.

Conexiant

February 26, 2026

Most Salivary Gland Neoplasms Found to Be Benign in Single-Center Study

Analysis of 50 cases shows moderate diagnostic agreement between FNAC and histopathology and identifies pleomorphic adenoma as the most common neoplasm.

Conexiant